The DOI matches its Crossref record.
Systemic Fungal Infections Caused by Candida Species: Epidemiology, Infection Process and Virulence Attributes
Abstract
Candida species, in particular C. albicans, represent a major threat to immunocompromised patients. Able to exist as a commensal on mucosal surfaces of healthy individuals, these opportunistic fungi frequently cause superficial infections of mucosae and skin. Furthermore, in hospital settings, Candida species may cause life-threatening invasive infections in a growing population of vulnerable patients. In fact, candidaemia is associated with the highest crude mortality of all bloodstream infections. Candida cells may enter the bloodstream by direct penetration from epithelial tissues, due to damage of barriers in the body caused by surgery, polytrauma or drug treatment, or may spread from biofilms produced on medical devices. From the bloodstream, cells may infect almost all organs but appear to prefer certain organs depending upon the route of infection. The exact mechanisms by which Candida cells survive the challenge of the blood environment and escape from the bloodstream to cause deep-seated infections have not yet been elucidated, but various investigations are reviewed. It is clear, however, that Candida must have particular attributes which enable the organism to survive and grow within the environment of healthy individuals and to invade tissues in the immunocompromised host. Most studies have focussed on C. albicans and this review will therefore summarise work on the various known virulence factors and methods used to identify further virulence attributes of this fungus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is noteworthy, however, that during dissemination, fungi are likely exposed only briefly to the bloodstream before they enter the target organs and hence that early survival may be crucial for successful systemic infections (71).”
From A novel hybrid iron regulation network combines features from pathogenic and nonpathogenic yeasts (2016) · cites this paper as [71]
Citations
Cited by
Sorted by citations
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Self-citationCandida albicans dimorphism as a therapeutic target
Jacobsen, I. D., Wilson, D., Wächtler, B., Brunke, S., Naglik, J. R., & Hube, B. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.152 · Cited by 363
Self-citationCellular interactions of Candida albicans with human oral epithelial cells and enterocytes
Dalle, F., Wächtler, B., L’Ollivier, C., Holland, G., Bannert, N., Wilson, D., Labruère, C., Bonnin, A., & Hube, B. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01394.x · Cited by 371
“albicans cells invade through the epithelial barrier of the gut into the bloodstream and spread throughout the body (Mavor et al., 2005).”
BackgroundSelf-citationCryptococcal cell morphology affects host cell interactions and pathogenicity
Okagaki, L. H., Strain, A. K., Nielsen, J. N., Charlier, C., Baltes, N. J., Chrétien, F., Heitman, J., Dromer, F., & Nielsen, K. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000953 · Cited by 345
“based on environmental cues or stage of infection [4,5,6].”
BackgroundWächtler, B., Wilson, D., Haedicke, K., Dalle, F., & Hube, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017046 · Cited by 282
“albicans without any sign of disease [1,2,3].”
Self-citation
Metadata
- Authors
- Mavor, A., Thewes, S., & Hube, B.
- Affiliations
- Robert Koch Institute (DE)
- Corresponding author
- Hube, B.
- ORCID
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-12-01
- Volume
- 6
- Issue
- 8
- Pages
- 863-874
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2152663489
- Cited by
- 252
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 9 · 2022: 11 · 2021: 18 · 2020: 15 · 2019: 15 · 2018: 8 · 2017: 9 · 2016: 16 · 2015: 18 · 2014: 15 · 2013: 14 · 2012: 9
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Robert Koch Institut
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- systemic candidiasis, Candida albicans, candidemia, invasive fungal infections, virulence factors, immunocompromised patients, opportunistic fungal pathogens, bloodstream infection, fungal pathogenesis, epidemiology
- MeSH terms
- Candida, Candidiasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review